Topic

Virginia

A collection of 501 issues

How to Get Carbaglu (Carglumic Acid) Covered by Aetna CVS Health in Virginia: Appeals Guide and Templates

Answer Box: Fast Track to Carbaglu Coverage Carbaglu (carglumic acid) is covered by Aetna CVS Health in Virginia for FDA-approved NAGS deficiency with prior authorization. To get approved: 1. Submit PA request with genetic/biochemical confirmation of NAGS deficiency plus elevated plasma ammonia labs 2. If denied, file internal appeal

Renewing Amvuttra (Vutrisiran) Coverage with Aetna CVS Health in Virginia: Documentation, Timelines & Appeal Rights

Answer Box: Renewing Amvuttra (vutrisiran) with Aetna CVS Health in Virginia requires annual documentation showing continued benefit and meeting original criteria. Submit renewal 30 days before expiration with updated clinical notes, labs (sTTR, NT-proBNP), cardiac function tests, and evidence of treatment response. If denied, Virginia's Bureau of Insurance

How to Get Cabometyx (Cabozantinib) Covered by Aetna CVS Health in Virginia: PA Requirements, Appeal Process & Forms

Answer Box: Getting Cabometyx Covered by Aetna CVS Health in Virginia Key Challenge: Cabometyx (cabozantinib) is excluded from Aetna's 2024 Advanced Control formulary, meaning standard coverage is denied. However, Virginia patients can pursue a formulary exception through Aetna's medical necessity process. Fastest Path to Approval: 1.

Getting Pyrukynd (Mitapivat) Covered by Aetna CVS Health in Virginia: Complete Guide to Prior Authorization and Appeals

Answer Box: Your Path to Pyrukynd Coverage Getting Pyrukynd (mitapivat) covered by Aetna CVS Health in Virginia requires prior authorization with strict genetic and clinical criteria. You'll need confirmed pyruvate kinase deficiency with at least two PKLR gene variants (one missense), hemoglobin ≤10 g/dL or significant transfusion

Coding That Helps Get Elaprase (Idursulfase) Approved in Virginia with UnitedHealthcare: ICD-10, HCPCS/J-Code, and NDC Guide

Answer Box: Getting Elaprase Covered by UnitedHealthcare in Virginia Fast track to approval: Use ICD-10 code E76.1 (Hunter syndrome), HCPCS J1743 for billing, and NDC 54092-0700-01. Submit prior authorization through UnitedHealthcare Provider Portal with enzymatic/genetic test results confirming Hunter syndrome diagnosis. If denied, file Virginia external review using

How to Get Joenja (leniolisib) Covered by Aetna CVS Health in Virginia: Timeline, Appeals, and Prior Authorization Guide

Answer Box: Getting Joenja (leniolisib) Covered by Aetna CVS Health in Virginia Fastest Path to Approval: Aetna typically approves specialty medications like Joenja within 24 hours for eligible requests, though standard review takes up to 14 days. First step today: Have your prescriber submit a prior authorization through CVS Specialty

How to Get Imbruvica (ibrutinib) Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Imbruvica Covered by Blue Cross Blue Shield in Virginia Yes, Imbruvica (ibrutinib) is covered by Blue Cross Blue Shield plans in Virginia, but requires prior authorization. Your doctor must document medical necessity and often prove you've tried preferred BTK inhibitors first. If denied, Virginia'

How to Get Vigabatrin (Sabril) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization Guide

Answer Box: Getting Vigabatrin Covered by Aetna CVS Health in Virginia Fast track to approval: Vigabatrin requires prior authorization from Aetna CVS Health with mandatory REMS enrollment for prescriber, patient, and pharmacy. Document two failed antiepileptic drugs, complete baseline vision testing, and submit through CVS Specialty Pharmacy. If denied, Virginia&

Renewing Qalsody (Tofersen) Approval with UnitedHealthcare in Virginia: Complete Guide to Documentation, Timelines, and Appeals

Answer Box: Renewing Your Qalsody Coverage Getting your Qalsody (tofersen) renewed with UnitedHealthcare in Virginia requires starting 6-8 weeks before your current approval expires. You'll need updated ALSFRS-R scores, neurofilament light chain (NfL) levels showing continued benefit, and documentation of SOD1 mutation status. Submit through the UnitedHealthcare provider

Getting Imbruvica (Ibrutinib) Covered by Aetna CVS Health in Virginia: Forms, Appeals, and Step Therapy Rights

Quick Answer: Your Path to Approval Imbruvica (ibrutinib) requires prior authorization from Aetna CVS Health but no step therapy for CLL/SLL. In Virginia, you have strong appeal rights: 72-hour step therapy override decisions, 180 days to appeal denials, and external review through the State Corporation Commission using Form 216-A.